A Dried Blood Spot Companion Diagnostic to Measure Neuroendocrine Changes in ADHD.
A Dried Blood Spot Companion Diagnostic to Measure Neuroendocrine Changes in ADHD.
批准号:
10091652
负责人:
Ekaterina A Placzek
金额:
$5.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-08-15 至 2021-02-14
关键词:
AddressAgeAllopregnanoloneAlternative TherapiesAttention deficit hyperactivity disorderBedside TestingsBiologicalBiological AssayBloodBlood specimenChildClinicalClinical ResearchCollectionComplementDetectionDevelopmentDiseaseDisease remissionEvaluationFutureGlutamatesGoalsGoldHealth SciencesHealthcare IndustryHeterogeneityHome environmentHyperactive behaviorImpulsivityIndividualKnowledgeKynurenineLaboratoriesLiquid ChromatographyLiquid substanceMeasuresMethodsModalityMonitorNatureNeurobiologyNeurodevelopmental DisorderNeurosecretory SystemsNeurotransmittersOregonOutcomePathologyPatientsPatternPerformancePharmaceutical PreparationsPhasePopulation ControlPrediction of Response to TherapyProcessQuestionnairesRandomizedRecoveryReproducibilityResearchSamplingSensitivity and SpecificitySerotoninSmall Business Innovation Research GrantSourceSpottingsSteroidsSymptomsTestingTreatment ProtocolsTreatment outcomeUniversitiesUrineValidationWhole BloodWorkalternative treatmentanalytical methodbaseclinically actionableclinically relevantcompanion diagnosticscontrol trialcostdesigndevelopmental diseasedietary supplementsevidence baseflexibilitygamma-Aminobutyric Acidinattentionminimally invasiveneurosteroidspediatric patientspersonalized medicinepoint of careprimary outcomeprototypereduce symptomsresearch clinical testingresponseside effectstandard of caresuccesssymptomatologytandem mass spectrometrytooltreatment adherencetreatment responseurinary
中文摘要
修订后的摘要
注意缺陷多动障碍(ADHD)是一种常见的神经发育障碍,以注意力不集中、多动和冲动为特征。刺激疗法可以有效地缓解ADHD症状;然而,由于ADHD的神经生物学异质性,一些患者对此无反应,或产生不良副作用。这在临床寻求替代治疗方案的过程中创造了一个反复试验的过程。目前,还没有广泛使用的实验室测试来测量ADHD的临床可操作的神经内分泌分析,可以提供足够的治疗成功和缓解预测。该项目将开发ADHD的配套诊断,以补充现有的症状评估问卷,这些问卷是治疗结果的间接衡量标准。拟议的配套诊断包括开发一种临床测试,用于检测干血斑(DBS)中分析的神经内分泌分子-GABA、别孕酮、谷氨酸、5-羟色胺和犬尿氨酸,因为其具有微创性质。我们将使用俄勒冈健康与科学大学学术合作者团队在一项积极的随机对照试验中收集的来自ADHD儿童的预先存在的全血样本,以评估和确认ADHD患者调节失调的神经内分泌张力。具体目标:1.建立并验证DBS中GABA和别孕酮的分析方法。我们将确定分析参数,包括线性、回收率、精密度等,并通过将DBS与液体血液分析进行比较来确认准确性,液体血液分析是目前公认的金标准方法。1.b)合并谷氨酸、5-羟色胺和犬尿氨酸分析物,以便同时分析。2.使用无药物治疗的ADHD患儿的DBS样本评估临床测试的性能。
这些目标的完成将成为对ADHD患者GABA、别孕酮、谷氨酸、5-羟色胺和犬尿氨酸水平进行全面验证的DBS测试的概念验证。这将为第二阶段奠定基础,开发一项全面的临床研究,检查ADHD患者使用的刺激剂、非刺激剂和营养补充剂对神经内分泌参数的影响。
英文摘要
REVISED ABSTRACT
Attention Deficit Hyperactivity Disorder (ADHD) is a common neurodevelopmental disorder marked by inattention, hyperactivity and impulsivity. Stimulant therapies can be effective for alleviating ADHD symptoms; however, due to neurobiological heterogeneity of ADHD, some patients are non-responders, or develop undesirable side effects. This creates a process of trial-and-error in the clinical pursuit of alternative treatment options. Currently there are no widely utilized laboratory tests that measure clinically actionable neuroendocrine analytes in ADHD that can provide adequate prediction of treatment success and remission. This project will develop a companion diagnostic for ADHD to complement existing symptom evaluation questionnaires, which are indirect measures of treatment outcome. The proposed companion diagnostic encompasses developing a clinical test for neuroendocrine molecules – GABA, allopregnanolone, glutamate, serotonin and kynurenine analyzed in dried blood spot (DBS) due to its minimally-invasive nature. We will use pre-existing whole blood samples from children with ADHD collected as part of an active randomized control trial by a team of academic collaborators at Oregon Health & Science University to evaluate and confirm dysregulated neuroendocrine tone in ADHD. Specific aims: 1. A) Develop and validate an analytical assay for GABA and allopregnanolone in DBS. We will determine analytical parameters, including linearity, recovery, precision, etc., and confirm accuracy by comparing DBS to liquid blood analysis, which is the currently accepted gold standard method. 1. B) Incorporate glutamate, serotonin and kynurenine analytes for simultaneous analysis. 2. Evaluate the performance of the clinical test using DBS samples from medication-free pediatric patients with ADHD.
Completion of these aims will serve as proof-of-concept for a fully validated DBS test for baseline (no treatment) levels of GABA, allopregnanolone, glutamate, serotonin and kynurenine in ADHD. This will establish the basis for Phase II, developing a comprehensive clinical study that will examine the changes in neuroendocrine parameters in response to stimulants, non-stimulants and nutritional supplements used in ADHD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: